Abstract
Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Letters in Drug Design & Discovery
Title: Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity
Volume: 5 Issue: 5
Author(s): Therese E. Malliavin, Helene Munier-Lehman and Veronique Stoven
Affiliation:
Keywords: Mycobacterium tuberculosis, GMPK, Guanylate monophosphate kinase, Virtual screening, ICM
Abstract: Guanylate kinases (GMPK) from Mycobacterium tuberculosis, Mus musculus and Saccharomyces cereviae were submitted to virtual screening in order to determine protein-ligand interactions specific to M. tuberculosis. The opening of the cleft between CORE, LID and GMP domains was found to have a large influence on the established interactions and on the determination of ligands binding specifically to the M. tuberculosis GMPK. An extended definition of the active site pocket, allowing to be more discriminant between Mycobacterium tuberculosis and M. musculus, is given. A virtual screening run with the extended pocket definition, was used to select compounds having high docking scores on M. tuberculosis GMPK and low ones on M. musculus GMPK. The protein residues involved in hydrogen bonds with ligands were the same than in the GMPK-GMP complex, but the chemical functions of the ligand involved in these hydrogen bonds are often different. On the other hand, the hydrophobic interactions are different from the ones observed in the GMPK-GMP structure, and may be a way to increase the specificity between the M. tuberculosis and M. musculus GMPKs.
Export Options
About this article
Cite this article as:
Malliavin E. Therese, Munier-Lehman Helene and Stoven Veronique, Virtual Screening of the Guanylate Monophosphate Kinase (GMPK) Family: Investigating the Rules of Ligand Specificity, Letters in Drug Design & Discovery 2008; 5 (5) . https://dx.doi.org/10.2174/157018008784912045
DOI https://dx.doi.org/10.2174/157018008784912045 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Contrast Enhanced Sonography for Diagnosis of (Peri-) Splenic Pathology
Current Medical Imaging Role of Cytokines in Chlamydia trachomatis Protective Immunity and Immunopathology
Current Pharmaceutical Design Synthesis and Antimycobacterial Activity of Highly Functionalised Pyrrolothiazole Derivatives
Letters in Drug Design & Discovery Lipids as Biomarkers of Cancer and Bacterial Infections
Current Medicinal Chemistry Epidemiology of Gout: Perspectives from the Past
Current Rheumatology Reviews Applying Knowledge of Enzyme Biochemistry to the Prediction of Functional Sites for Aiding Drug Discovery
Current Topics in Medicinal Chemistry Pre-Exposure Prophylaxis - One More Tool for HIV Prevention
Current HIV Research Advancements in Adjuvanticity of Bioactive Inorganic and Organic Compounds
Endocrine, Metabolic & Immune Disorders - Drug Targets Particulate and Vesicular Drug Carriers in the Management of Tuberculosis
Current Drug Delivery Overview of Anti-Tuberculosis (TB) Drugs and Their Resistance Mechanisms
Mini-Reviews in Medicinal Chemistry Promising Drugs Against Tuberculosis
Recent Patents on Anti-Infective Drug Discovery Synthesis and Pharmacological Activities of Oxadiazole and Pyrimidine Bearing Thiocoumarin Derivatives
Current Microwave Chemistry Innate Immunity and Primary Biliary Cirrhosis
Current Molecular Medicine Polymorphisms of Human N-Acetyltransferases and Cancer Risk
Current Drug Metabolism Recent Achievements in the Chemistry of 1,2-Diazines
Current Organic Chemistry Functional PLGA NPs for Oral Drug Delivery: Recent Strategies and Developments
Mini-Reviews in Medicinal Chemistry Classification of Small GTPases with Hybrid Protein Features and Advanced Machine Learning Techniques
Current Bioinformatics Synthesis of 2-, 3- or 4-phenylsubtituted Chalcones Based on 4- phenylamino-6-nitro-2-[(E)-2-phenylvinyl]quinoline, Evaluation of their Antimicrobial and Antifungal Activity
Letters in Drug Design & Discovery New Insights in Design and Development of Antitubercular Drugs
Current Bioactive Compounds Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry